Is fibromyalgia an autoimmune disease? A necessary reassessment based on current evidence

Authors

Keywords:

fibromyalgia, autoimmunity, cytokines, central sensitization, antibodies, chronic pain

Abstract

Fibromyalgia has traditionally been defined as a non-inflammatory chronic pain syndrome, primarily mediated by central sensitization mechanisms. However, recent evidence suggests that a subset of patients may exhibit immunologic features, potentially of autoimmune origin. Studies such as that by Goebel et al. have shown that passive transfer of IgG from fibromyalgia patients induces pain-related symptoms in murine models. Elevated levels of inflammatory cytokines and a high prevalence of antinuclear antibodies have also been documented in these patients. The coexistence of FM with systemic autoimmune diseases further supports the hypothesis of underlying immune dysregulation. While fibromyalgia cannot yet be classified as a classic autoimmune disease, an immunologic phenotype may be present in a significant proportion of patients. This evolving perspective may reshape diagnostic and therapeutic approaches, fostering a more personalized model of care.

Downloads

Download data is not yet available.

References

Goebel A, Krock E, Gentry C, et al. Passive transfer of fibromyalgia symptoms from patients to mice. J Clin Invest. 2021;131(13):e144201. https://doi.org/10.1172/JCI144201

Üçeyler N, Häuser W, Sommer C. Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord. 2011;12:245. https://doi.org/10.1186/1471-2474-12-245

López-Ruiz M, Peralta-Ramírez MI, Pérula-de Torres LA, et al. High prevalence of antinuclear antibodies in patients with fibromyalgia: a cross-sectional study. Clin Rheumatol. 2015;34(7):1215–1219. https://doi.org/10.1007/s10067-014-2686-9

Wolfe F, Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheumatol. 2004;31(4):695–700.

Torrente-Segarra V, Salgado E, Martínez-Estupiñán L, et al. Fibromyalgia prevalence and related factors in patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 2017;35 Suppl 105(3):28–33.

Yusof MYM, Vital EM, Emery P. Is fibromyalgia part of the spectrum of autoimmune rheumatic diseases? Best Pract Res Clin Rheumatol. 2019;33(6):101429. https://doi.org/10.1016/j.berh.2020.101429

Published

2026-02-14

How to Cite

1.
Theran León JS, Otero Rueda AF. Is fibromyalgia an autoimmune disease? A necessary reassessment based on current evidence. Rev. cuba. de Reumatol. [Internet]. 2026 Feb. 14 [cited 2026 Feb. 22];28:e1469. Available from: https://revreumatologia.sld.cu/index.php/reumatologia/article/view/1469

Issue

Section

Letters to the editor